Trail Overexpression Inversely Correlates with Histological Differentiation in Intestinal-Type Sinonasal Adenocarcinoma

Table 1

Clinicopathological data of patients and TRAIL oncoprotein expression percentage.

Patient	Age	Sex	T	Grade	CH	CHT	RT	Relapse	Trail%
1	70	M	T2	3	No	No	Yes	Yes	70
2	55	M	T3	1	Yes	Yes	Yes	No	10
3	67	M	T3	2	No	Yes	Yes	No	60
4	60	F	T1	1	Yes	No	No	No	5
5	62	M	T3	3	Yes	Yes	Yes	Yes	80
6	54	M	T3	2	Yes	No	Yes	No	35
7	54	M	T3	2	Yes	No	Yes	No	50
8	74	M	T3	1	Yes	No	Yes	No	20
9	74	M	T2	2	Yes	No	Yes	Yes	55
10	58	M	T1	1	Yes	No	Yes	No	2
11	74	M	T2	3	Yes	No	Yes	Yes	80
12	70	M	T2	2	Yes	No	Yes	No	50
13	72	M	T3	1	Yes	No	Yes	No	3
14	68	M	T3	3	Yes	No	Yes	No	70
15	77	M	T3	2	Yes	No	Yes	No	75
16	67	M	T3	1	Yes	No	Yes	No	45
17	77	M	T2	2	Yes	No	No	Yes	60
18	65	M	T3	3	Yes	No	Yes	Yes	75
19	63	M	T2	1	Yes	No	Yes	No	55
20	61	F	T1	1	Yes	No	Yes	No	5
21	65	M	T2	2	Yes	No	No	No	25
22	61	M	T4a	3	Yes	No	Yes	Yes	90
23	76	M	T4b	3	Yes	No	No	Yes	80

T: tumor extension, CH: surgery, CHT: chemotherapy, RT: radiotherapy.